What is the market doing?
What the tape says about GSK
GSK plc is +42% over the past year while the S&P 500 is +23%: 19 points ahead of the market.
+42%
1-year return · S&P 500 +23%
- vs 200-day average
- +0.38%
vs 200-day average · close to trend
- RSI (14)
- 47
RSI (14) · neutral
- Below its 52-week high
- −14%
Below its 52-week high
Details›
- Last close2026-08-26
- $51.44
- 1 monthS&P 500 +3.7%
- +1.4%
- 1 yearS&P 500 +23%
- +42%
- 5 yearsS&P 500 +87%
- +57%
- vs 50-day average$51.44
- −0.01%
- 52-week high
- $60.14
- 52-week low
- $36.35
- Annualised volatility
- 27%
| Year | Return |
|---|---|
| 2026 (year to date) | +6.7% |
| 2025 | +51% |
| 2024 | −5.1% |
| 2023 | +9.7% |
| 2022 | −17% |
| 2021 | +27% |
| 2020 | −18% |
| 2019 | +29% |
| 2018 | +14% |
| 2017 | −3.0% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 9 of 10 | +2.9% |
| Feb | 10 | 5 of 10 | +1.3% |
| Mar | 10 | 8 of 10 | +1.9% |
| Apr | 10 | 6 of 10 | +1.3% |
| May | 10 | 6 of 10 | +1.5% |
| Jun | 10 | 4 of 10 | −1.2% |
| Jul | 11 | 6 of 11 | +0.14% |
| Aug | 11 | 5 of 11 | −0.33% |
| Sep | 10 | 4 of 10 | −1.3% |
| Oct | 10 | 4 of 10 | −0.37% |
| Nov | 10 | 6 of 10 | +1.6% |
| Dec | 10 | 8 of 10 | +1.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - General
Ranks #8 of 16 by Smart Score